Llc Lipizzaner serves as Executive at NeuBase Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Llc Lipizzaner has executed 2 insider transactions totaling $20.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 9, 2020 involved purchasing 1,275 shares valued at $9.9K.
Llc Lipizzaner currently holds 12,525 shares of NeuBase Therapeutics, Inc. (NBSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Llc Lipizzaner has been a net buyer of NBSE stock. They have purchased $20.0K and sold $0 worth of shares.
Llc Lipizzaner's most recent insider trade was on Jun 9, 2020, when they purchased 1,275 shares at $7.73 per share.
Get notified when new Form 4 filings are submitted
| $8.09 |
| Discretionary |